CIFLOX Side Effects

7018903-0 | Aphasia, Cardio-respiratory Arrest, Haemorrhage Intracranial, Headache, Hemiplegia, Renal Failure, Status Epilepticus, Subdural Haematoma
on Sep 22, 2010 Female patient from FRANCE , 85 years of age, weighting 143.3 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?) and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cardio-respiratory arrest, haemorrhage intracranial, headache (What is headache?), hemiplegia, renal failure, status epilepticus, subdural haematoma. Ciflox dosage: . During the same period patient was treated with PREVISCAN (Long Term Treatment) (View Previscan Review and Previscan Label ), PERINDOPRIL ERBUMINE (Long Term Treatment) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), FUROSEMIDE (Long Term Treatment) (View Furosemide Review and Furosemide Label ), HEMIGOXINE NATIVELLE (Long Term Treatment) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), KALEORID (Long Term Treatment) (View Kaleorid Review and Kaleorid Label ), CARDENSIEL (Long Term Treatment) (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6940574-X | Catheter Site Haemorrhage, Thrombocytopenia
Patient was taking Ciflox (View Usage). Patient had the following side effects: catheter site haemorrhage, thrombocytopenia on Aug 19, 2010 from FRANCE Additional patient health information: Male patient , 63 years of age, . Ciflox dosage: Unit Dose: 400 Mg. During the same period patient was treated with FORTUM (View Fortum Review and Fortum Label ). Patient was hospitalized.

6930084-8 | Clostridium Test Positive, Pseudomembranous Colitis
Adverse event was reported on Aug 10, 2010 by a Female patient taking Ciflox (View Usage) (Dosage: Total Daily Dose: 800 Mg) was diagnosed with lung infection and. Location: FRANCE , 76 years of age, After Ciflox was administered, patient had the following side effects: clostridium test positive, pseudomembranous colitis. During the same period patient was treated with AUGMENTIN '125' (Total Daily Dose: 3000 Mg) (View Augmentin '125' Review and Augmentin '125' Label ), PIPERACILLIN AND TAZOBACTAM (Total Daily Dose: 12 G) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ). Patient was hospitalized.

6914571-4 | Haematoma, Haematuria, International Normalised Ratio Increased, Petechiae
on Jul 28, 2010 Female patient from FRANCE , 89 years of age, was diagnosed with infection (What is infection?), thrombosis prophylaxis, atrial fibrillation (What is atrial fibrillation?) and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, haematuria, international normalised ratio increased, petechiae. Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with KARDEGIC (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Kardegic Review and Kardegic Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), PREVISCAN (Dependent On Inr Value) (View Previscan Review and Previscan Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.


6911702-7 | Toxic Skin Eruption
on Jul 30, 2010 Male patient from FRANCE , 77 years of age, was diagnosed with erysipelas and was treated with Ciflox (View Usage). Patient had the following side effects: toxic skin eruption. Ciflox dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6911692-7 | Epistaxis, Gingival Bleeding, Haematemesis, Haemorrhagic Anaemia, International Normalised Ratio Increased
Patient was taking Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: epistaxis, gingival bleeding, haematemesis, haemorrhagic anaemia, international normalised ratio increased on Jul 28, 2010 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), peripheral ischaemia and. Ciflox dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), SMECTA (View Smecta Review and Smecta Label ), LOXEN (View Loxen Review and Loxen Label ), IMODIUM (View Imodium Review and Imodium Label ), NEXIUM (View Nexium Review and Nexium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6911691-5 | Rash Erythematous, Skin Exfoliation
Adverse event was reported on Jul 28, 2010 by a Female patient taking Ciflox (View Usage) (Dosage: Total Daily Dose: 500 Mg Unit Dose: 750 Mg) . Location: FRANCE , 79 years of age, Patient experienced the following unwanted or unexpected effects: rash erythematous, skin exfoliation. During the same period patient was treated with TRAMADOL HCL (As Used: 100/2 Mg/ml) (View Tramadol Hcl Review and Tramadol Hcl Label ), DORIBAX (View Doribax Review and Doribax Label ), ARIXTRA (As Used: 2.5 + 0.5 Mg/ml) (View Arixtra Review and Arixtra Label ), ADANCOR (View Adancor Review and Adancor Label ), ATACAND (View Atacand Review and Atacand Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ), SPASFON (View Spasfon Review and Spasfon Label ). Patient was hospitalized.

6901220-4 | Multi-organ Failure, Renal Failure
on Jul 28, 2010 Male patient from FRANCE , 90 years of age, was diagnosed with device related infection and was treated with Ciflox (View Usage). Patient had the following side effects: multi-organ failure, renal failure. Ciflox dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), N METHYL GENTAMYCINE SULPHATE (View N-methyl Gentamycine Sulphate Review and N-methyl Gentamycine Sulphate Label ), AXEPIM (View Axepim Review and Axepim Label ). Patient was hospitalized.

6871463-7 | Anaemia, Asthenia, Dyspnoea, Fall, Haematoma, International Normalised Ratio Increased, Pallor
on Jul 20, 2010 Female patient from FRANCE , 83 years of age, was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: anaemia, asthenia, dyspnoea, fall (What is fall?), haematoma, international normalised ratio increased, pallor. Ciflox dosage: Total Daily Dose: 500 Mg Unit Dose: 250 Mg. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6871455-8 | Abnormal Behaviour, Arthralgia, Decreased Appetite, Myalgia, Tendon Disorder, Uveitis, Visual Acuity Reduced
Patient was taking Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, arthralgia, decreased appetite, myalgia, tendon disorder, uveitis, visual acuity reduced on Jul 19, 2010 from FRANCE Additional patient health information: Male patient , 84 years of age, was diagnosed with prostatitis and. Ciflox dosage: Total Daily Dose: 200 Mg. During the same period patient was treated with PREVISCAN (Unit Dose: 20 Mg) (View Previscan Review and Previscan Label ), NISIS (Unit Dose: 40 Mg) (View Nisis Review and Nisis Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LASIX (View Lasix Review and Lasix Label ), DOLIPRANE (Total Daily Dose: 4 G) (View Doliprane Review and Doliprane Label ), LANTUS (1-0-0) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6871454-6 | Anaemia, Asthenia, Dyspnoea, Fall, International Normalised Ratio Increased, Mucosal Discolouration, Subcutaneous Haematoma
Adverse event was reported on Jul 20, 2010 by a Female patient taking Ciflox (View Usage) (Dosage: 2 Dosage Form Per Day) . Location: FRANCE , 83 years of age, Patient had the following side effects: anaemia, asthenia, dyspnoea, fall (What is fall?), international normalised ratio increased, mucosal discolouration, subcutaneous haematoma. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6867539-0 | Pyrexia, Skin Exfoliation
on Jul 19, 2010 Female patient from FRANCE , 87 years of age, was diagnosed with intertrigo and was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: pyrexia, skin exfoliation. Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with PYOSTACINE (Total Daily Dose: 1000 Mg Unit Dose: 500 Mg) (View Pyostacine Review and Pyostacine Label ), METFORMIN (Unit Dose: 500 Mg) (View Metformin Review and Metformin Label ), AMLOR (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Amlor Review and Amlor Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ). Patient was hospitalized.

6786716-0 | Anaemia, Asthenia, Dyspnoea, Fall, Haematoma, International Normalised Ratio Increased, Pallor
on Jun 10, 2010 Female patient from FRANCE , 83 years of age, was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, dyspnoea, fall (What is fall?), haematoma, international normalised ratio increased, pallor. Ciflox dosage: Total Daily Dose: 500 Mg Unit Dose: 250 Mg. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6783780-X | Anaemia, Asthenia, Dyspnoea, Fall, Haematoma, International Normalised Ratio Increased, Pallor
Patient was taking Ciflox (View Usage). Patient had the following side effects: anaemia, asthenia, dyspnoea, fall (What is fall?), haematoma, international normalised ratio increased, pallor on Jun 10, 2010 from FRANCE Additional patient health information: Female patient , 83 years of age, . Ciflox dosage: Total Daily Dose: 500 Mg Unit Dose: 250 Mg. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6768450-6 | Dizziness, Fall, Post-traumatic Pain
Adverse event was reported on May 31, 2010 by a Female patient taking Ciflox (View Usage) (Dosage: Unit Dose: 500 Mg) . Location: FRANCE , 90 years of age, After Ciflox was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), post-traumatic pain. During the same period patient was treated with PAROXETINE (Long Term Treatment) (View Paroxetine Review and Paroxetine Label ), MOPRAL (View Mopral Review and Mopral Label ), PARACETAMOL (3 To 4 Tablets Per Day) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6768443-9 | Atrophic Glossitis, Cheilitis, Dermatitis Exfoliative, Face Oedema, Hyperthermia, Inflammation, Lymphadenopathy, Oedema Peripheral
on Jun 07, 2010 Male patient from FRANCE , 48 years of age, was diagnosed with pleural disorder (What is pleural disorder?) and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: atrophic glossitis, cheilitis, dermatitis exfoliative, face oedema, hyperthermia, inflammation, lymphadenopathy, oedema peripheral. Ciflox dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), FORTUM (View Fortum Review and Fortum Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), FLAGYL (View Flagyl Review and Flagyl Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ). Patient was hospitalized.

6766514-4 | Dizziness, Fall, Post-traumatic Pain
on May 31, 2010 Female patient from FRANCE , 90 years of age, was treated with Ciflox (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), post-traumatic pain. Ciflox dosage: Unit Dose: 500 Mg. During the same period patient was treated with PAROXETINE HCL (Long Term Treatment) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), MOPRAL (View Mopral Review and Mopral Label ), PARACETAMOL (3 To 4 Tablets Per Day) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6755826-6 | Cytolytic Hepatitis, Dermatitis, Dermatitis Exfoliative, Haematuria, Mononucleosis Syndrome, Multi-organ Failure, Pancytopenia, Rash, Rectal Haemorrhage
Patient was taking Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: cytolytic hepatitis, dermatitis, dermatitis exfoliative, haematuria, mononucleosis syndrome, multi-organ failure, pancytopenia, rash (What is rash?), rectal haemorrhage on May 28, 2010 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with respiratory tract infection, unevaluable event and. Ciflox dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMIKIN (View Amikin Review and Amikin Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

6753812-3 | Cytolytic Hepatitis, Dermatitis Exfoliative, Haematuria, Mononucleosis Syndrome, Pancytopenia, Rectal Haemorrhage, Renal Failure Acute
Adverse event was reported on May 28, 2010 by a Male patient taking Ciflox (View Usage) (Dosage: ) was diagnosed with respiratory tract infection and. Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, dermatitis exfoliative, haematuria, mononucleosis syndrome, pancytopenia, rectal haemorrhage, renal failure acute. During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AMIKIN (View Amikin Review and Amikin Label ), HEPARINE SODIQUE (View Heparine Sodique Review and Heparine Sodique Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

6535603-1 | Blood Amylase Increased, Cholestasis, Lipase Increased, Pancreatitis, Rash Maculo-papular, Transaminases Increased
on Dec 28, 2009 Female patient from FRANCE , 76 years of age, was diagnosed with hyperthermia and was treated with Ciflox (View Usage). Patient had the following side effects: blood amylase increased, cholestasis, lipase increased, pancreatitis, rash maculo-papular, transaminases increased. Ciflox dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ). Patient was hospitalized.

6535570-0 | Haematoma, Haemoptysis, International Normalised Ratio Increased
on Dec 30, 2009 Female patient from FRANCE , 94 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: haematoma, haemoptysis, international normalised ratio increased. Ciflox dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), APROVEL (View Aprovel Review and Aprovel Label ), ORAP (View Orap Review and Orap Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6532719-0 | Haematoma, Haemoptysis, International Normalised Ratio Increased
Patient was taking Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, haemoptysis, international normalised ratio increased on Dec 30, 2009 from FRANCE Additional patient health information: Female patient , 94 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Ciflox dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), APROVEL (View Aprovel Review and Aprovel Label ), ORAP (View Orap Review and Orap Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6532718-9 | Blood Amylase Increased, Cholestasis, Lipase Increased, Rash Maculo-papular, Transaminases Increased
Adverse event was reported on Dec 28, 2009 by a Female patient taking Ciflox (View Usage) (Dosage: ) was diagnosed with hyperthermia and. Location: FRANCE , 76 years of age, Patient had the following side effects: blood amylase increased, cholestasis, lipase increased, rash maculo-papular, transaminases increased. During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ). Patient was hospitalized.

6531156-2 | Blood Amylase Increased, Cholestasis, Lipase Increased, Rash Maculo-papular, Transaminases Increased
on Dec 28, 2009 Female patient from FRANCE , 76 years of age, was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: blood amylase increased, cholestasis, lipase increased, rash maculo-papular, transaminases increased. Ciflox dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ). Patient was hospitalized.

6521201-2 | Agranulocytosis, Asthenia, Hyperthermia
on Dec 22, 2009 Female patient from FRANCE , 52 years of age, was diagnosed with abdominal pain lower, hypertension and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, asthenia, hyperthermia. Ciflox dosage: Unit Dose: 500 Mg. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), SPASFON (View Spasfon Review and Spasfon Label ), ENTOCORT EC (View Entocort Ec Review and Entocort Ec Label ), FIVASA (View Fivasa Review and Fivasa Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), SMECTA (View Smecta Review and Smecta Label ). Patient was hospitalized.

6519100-5 | Mouth Ulceration, Oral Disorder, Oropharyngeal Blistering, Thrombocytopenia
Patient was taking Ciflox (View Usage). Patient had the following side effects: mouth ulceration, oral disorder, oropharyngeal blistering, thrombocytopenia on Dec 18, 2009 from FRANCE Additional patient health information: Male patient , 62 years of age, . Ciflox dosage: Unit Dose: 750 Mg. During the same period patient was treated with RIFADIN (Total Daily Dose: 1200 Mg Unit Dose: 600 Mg) (View Rifadin Review and Rifadin Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), NEXIUM (View Nexium Review and Nexium Label ), CRESTOR (View Crestor Review and Crestor Label ), AMLOR (View Amlor Review and Amlor Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6519099-1 | Arthralgia, Pyrexia, Sputum Increased, Vascular Purpura
Adverse event was reported on Dec 18, 2009 by a Female patient taking Ciflox (View Usage) (Dosage: Unit Dose: 750 Mg) . Location: FRANCE , 21 years of age, weighting 72.75 lb, After Ciflox was administered, patient had the following side effects: arthralgia, pyrexia, sputum increased, vascular purpura. During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), FORTUM (View Fortum Review and Fortum Label ). Patient was hospitalized.

6508788-0 | Aphasia, Atrial Fibrillation, Cerebrovascular Accident, Dehydration, Hypotension, International Normalised Ratio Increased, Loss Of Consciousness, Renal Failure Acute
on Dec 14, 2009 Female patient from FRANCE , 88 years of age, was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, dehydration, hypotension, international normalised ratio increased, loss of consciousness, renal failure acute. Ciflox dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

6479680-5 | Haemoptysis, Hypoprothrombinaemia
on Nov 30, 2009 Female patient from FRANCE , 64 years of age, was diagnosed with respiratory tract infection and was treated with Ciflox (View Usage). Patient had the following side effects: haemoptysis, hypoprothrombinaemia. Ciflox dosage: 2 Df One Day. During the same period patient was treated with PREVISCAN (1 Df) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6456139-2 | Fatigue, Hyperhidrosis, Hypoglycaemia, Respiratory Failure, Speech Disorder
Patient was taking Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: fatigue, hyperhidrosis, hypoglycaemia, respiratory failure, speech disorder on Nov 19, 2009 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with sepsis (What is sepsis?) and. Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with AMAREL (Total Daily Dose: 4 Mg Unit Dose: 4 Mg) (View Amarel Review and Amarel Label ), GLUCOPHAGE (Total Daily Dose: 3000 Mg Unit Dose: 1000 Mg) (View Glucophage Review and Glucophage Label ), HYZAAR (15/12,5 Mg / Day) (View Hyzaar Review and Hyzaar Label ), LERCANIDIPINE (As Used: 20 Mg Unit Dose: 20 Mg) (View Lercanidipine Review and Lercanidipine Label ), TEMERIT (As Used: 5 Mg Unit Dose: 5 Mg) (View Temerit Review and Temerit Label ), ALDACTONE (As Used: 25 Mg Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), KARDEGIC (As Used: 160 Mg Unit Dose: 16 Mg) (View Kardegic Review and Kardegic Label ), FLAGYL (Total Daily Dose: 2000 Mg Unit Dose: 500 Mg) (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

6456131-8 | Areflexia, Dysphagia, Weight Decreased
Adverse event was reported on Nov 23, 2009 by a Female patient taking Ciflox (View Usage) (Dosage: Unit Dose: 750 Mg) was diagnosed with pseudomonas infection, bacterial disease carrier, psychotic disorder (What is psychotic disorder?) and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: areflexia, dysphagia, weight decreased. During the same period patient was treated with VANCOMYCIN (Unit Dose: 500 Mg) (View Vancomycin Review and Vancomycin Label ), FUCIDINE CAP (Unit Dose: 500 Mg) (View Fucidine Cap Review and Fucidine Cap Label ), HALDOL DECANOAS (View Haldol Decanoas Review and Haldol Decanoas Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ).

6452919-8 | Coma, Malaise, Myoclonus, Status Epilepticus
on Nov 13, 2009 Male patient from FRANCE , 48 years of age, was diagnosed with prostatitis, bronchitis (What is bronchitis?) and was treated with Ciflox (View Usage). Patient had the following side effects: coma, malaise, myoclonus, status epilepticus. Ciflox dosage: Unit Dose: 400 Mg. During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), AMIKLIN (View Amiklin Review and Amiklin Label ). Patient was hospitalized.

6448584-6 | Dermatitis Bullous, Erythema, Photosensitivity Reaction, Rash Maculo-papular, Skin Lesion
on Nov 16, 2009 Male patient from FRANCE , 55 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: dermatitis bullous, erythema, photosensitivity reaction, rash maculo-papular, skin lesion. Ciflox dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), NOROXIN (View Noroxin Review and Noroxin Label ). Patient was hospitalized.

6448577-9 | Agitation, Cerebellar Ataxia, Chromatopsia, Confusional State, Dysaesthesia, Gait Disturbance, Hyperaesthesia, Impaired Self-care, Muscular Weakness
Patient was taking Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, cerebellar ataxia, chromatopsia, confusional state, dysaesthesia, gait disturbance, hyperaesthesia, impaired self-care, muscular weakness on Nov 09, 2009 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with pyrexia, acute myeloid leukaemia, bronchopulmonary aspergillosis and. Ciflox dosage: . During the same period patient was treated with ARACYTINE (D1 And D5) (View Aracytine Review and Aracytine Label ), CERUBIDINE (75 Mg At D1) (View Cerubidine Review and Cerubidine Label ), MYLOTARG (View Mylotarg Review and Mylotarg Label ), VFEND (View Vfend Review and Vfend Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

6428536-2 | Delirium, Hallucination
Adverse event was reported on Nov 03, 2009 by a Female patient taking Ciflox (View Usage) (Dosage: ) was diagnosed with bile duct stone and. Location: FRANCE , 52 years of age, Patient had the following side effects: delirium, hallucination. During the same period patient was treated with VIRAFERONPEG (Total Daily Dose: 12.8571 ?g) (View Viraferonpeg Review and Viraferonpeg Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), NEORAL (View Neoral Review and Neoral Label ), REBETOL (View Rebetol Review and Rebetol Label ), EFFEXOR (View Effexor Review and Effexor Label ), NOCTRAN (View Noctran Review and Noctran Label ), PRIMPERAN (View Primperan Review and Primperan Label ). Patient was hospitalized.

6419345-9 | Cholangitis, Cytolytic Hepatitis, Jaundice
on Oct 22, 2009 Female patient from FRANCE , 73 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), gastrooesophageal reflux disease and was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: cholangitis, cytolytic hepatitis, jaundice (What is jaundice?). Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with AUGMENTIN (Total Daily Dose: 3 G Unit Dose: 1 G) (View Augmentin Review and Augmentin Label ), DALACINE (Total Daily Dose: 1800 Mg Unit Dose: 600 Mg) (View Dalacine Review and Dalacine Label ), NEXIUM (Unit Dose: 40 Mg) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6412770-1 | Grand Mal Convulsion
on Oct 19, 2009 Male patient from FRANCE , 47 years of age, was diagnosed with prostatitis and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Ciflox dosage: . During the same period patient was treated with ANTIEPILEPTIC (Overdosage) (View Antiepileptic Review and Antiepileptic Label ). Patient was hospitalized.

6408141-4 | Delirium, Hallucination
Patient was taking Ciflox (View Usage). Patient had the following side effects: delirium, hallucination on Oct 13, 2009 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with bile duct stone and. Ciflox dosage: . During the same period patient was treated with VIRAFERON (Total Daily Dose: 12.8571 ?g) (View Viraferon Review and Viraferon Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), NEORAL (View Neoral Review and Neoral Label ), REBETOL (View Rebetol Review and Rebetol Label ), EFFEXOR (View Effexor Review and Effexor Label ), NOCTRAN (View Noctran Review and Noctran Label ), PRIMPERAN (View Primperan Review and Primperan Label ). Patient was hospitalized.

6408139-6 | Coma, Epilepsy
Adverse event was reported on Oct 15, 2009 by a Male patient taking Ciflox (View Usage) (Dosage: ) was diagnosed with prostatitis and. Location: FRANCE , 47 years of age, After Ciflox was administered, patient had the following side effects: coma, epilepsy (What is epilepsy?). Patient was hospitalized.

6403076-5 | Aphthous Stomatitis, Balanoposthitis, Conjunctivitis, Eye Irritation, Intertrigo
on Oct 08, 2009 Male patient from FRANCE , 66 years of age, was diagnosed with prostatitis and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: aphthous stomatitis, balanoposthitis, conjunctivitis, eye irritation, intertrigo. Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with GENTAMICINE (View Gentamicine Review and Gentamicine Label ), XATRAL (View Xatral Review and Xatral Label ). Patient was hospitalized.

6403073-X | Circulatory Collapse
on Oct 08, 2009 Male patient from FRANCE , 54 years of age, was diagnosed with antibiotic prophylaxis, anaesthesia, pain (What is pain?) and was treated with Ciflox (View Usage). Patient had the following side effects: circulatory collapse. Ciflox dosage: . During the same period patient was treated with SODIC PIPERACILLINE (View Sodic Piperacilline Review and Sodic Piperacilline Label ), TARGOCID (View Targocid Review and Targocid Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

6393155-3 | Blood Creatine Phosphokinase Increased, Myalgia
Patient was taking Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia on Sep 25, 2009 from FRANCE Additional patient health information: Female patient , 42 years of age, was diagnosed with diverticulitis and. Ciflox dosage: Total Daily Dose: 1000 Mg Unit Dose: 500 Mg. During the same period patient was treated with FLAGYL (Total Daily Dose: 1500 Mg Unit Dose: 500 Mg) (View Flagyl Review and Flagyl Label ).

6387120-X | Catatonia, Depression
Adverse event was reported on Sep 25, 2009 by a Female patient taking Ciflox (View Usage) (Dosage: Total Daily Dose: 500 Mg Unit Dose: 500 Mg) was diagnosed with bacterial pyelonephritis and. Location: FRANCE , 85 years of age, Patient experienced the following unwanted or unexpected effects: catatonia, depression (What is depression?). During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ), NEXIUM (View Nexium Review and Nexium Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

6379078-4 | Cerebral Haematoma, Haemorrhagic Stroke, Headache, Hemianopia, International Normalised Ratio Increased
on Sep 18, 2009 Female patient from FRANCE , 74 years of age, was diagnosed with diverticulitis, thrombosis prophylaxis, dyslipidaemia and was treated with Ciflox (View Usage). Patient had the following side effects: cerebral haematoma, haemorrhagic stroke, headache (What is headache?), hemianopia, international normalised ratio increased. Ciflox dosage: Total Daily Dose: 500 Mg Unit Dose: 500 Mg. During the same period patient was treated with PREVISCAN (Dose According To Inr) (View Previscan Review and Previscan Label ), FLAGYL (Total Daily Dose: 1500 Mg Unit Dose: 500 Mg) (View Flagyl Review and Flagyl Label ), LIPANTHYL (Total Daily Dose: 145 Mg Unit Dose: 145 Mg) (View Lipanthyl Review and Lipanthyl Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

6366524-5 | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Pulmonary Embolism
on Sep 08, 2009 Male patient from FRANCE , 67 years of age, was diagnosed with thrombosis and was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, pulmonary embolism (What is pulmonary embolism?). Ciflox dosage: . During the same period patient was treated with HEPARINE SODIQUE PANPHARMA (View Heparine Sodique Panpharma Review and Heparine Sodique Panpharma Label ), CLAVENTIN (5 G/200 Mg (clavulanate Potassium, Ticarcillin Disodium)) (View Claventin Review and Claventin Label ), DEROXAT (View Deroxat Review and Deroxat Label ), SERESTA (View Seresta Review and Seresta Label ), HAVLANE (View Havlane Review and Havlane Label ), ORGARAN (View Orgaran Review and Orgaran Label ). Patient was hospitalized.

6366523-3 | Erythema, Oral Disorder, Rash, Rash Pruritic, Toxic Skin Eruption
Patient was taking Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, oral disorder, rash (What is rash?), rash pruritic, toxic skin eruption on Sep 08, 2009 from FRANCE Additional patient health information: Male patient , 71 years of age, was diagnosed with klebsiella infection and. Ciflox dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FURADANTIN (View Furadantin Review and Furadantin Label ), HEMIGOXINE (Total Daily Dose: 0.125 Mg Unit Dose: 0.125 Mg) (View Hemigoxine Review and Hemigoxine Label ), TEMERIT (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Temerit Review and Temerit Label ), BUMEX (Total Daily Dose: 1 Mg Unit Dose: 1 Mg) (View Bumex Review and Bumex Label ), COVERSYL (As Used: 10) (View Coversyl Review and Coversyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ).

6366517-8 | C-reactive Protein Increased, Creatinine Renal Clearance Decreased, Dehydration, Haematemesis, International Normalised Ratio Increased, Neutrophil Count Increased
Adverse event was reported on Sep 08, 2009 by a Male patient taking Ciflox (View Usage) (Dosage: Total Daily Dose: 500 Mg Unit Dose: 500 Mg) . Location: FRANCE , 86 years of age, Patient had the following side effects: c-reactive protein increased, creatinine renal clearance decreased, dehydration, haematemesis, international normalised ratio increased, neutrophil count increased. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ), SINEMET (Total Daily Dose: 100 Mg Unit Dose: 250 Mg) (View Sinemet Review and Sinemet Label ), SINEMET CR (Total Daily Dose: 100 Mg Unit Dose: 100 Mg) (View Sinemet Cr Review and Sinemet Cr Label ), IMOVANE (Total Daily Dose: 7.5 Mg Unit Dose: 7.5 Mg) (View Imovane Review and Imovane Label ), DILTIAZEM HCL (Total Daily Dose: 120 Mg Unit Dose: 60 Mg) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), NITROGLYCERIN (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Nitroglycerin Review and Nitroglycerin Label ), ZOCOR (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Zocor Review and Zocor Label ), FRACTAL (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Fractal Review and Fractal Label ). Patient was hospitalized.

6361167-1 | C-reactive Protein Increased, Creatinine Renal Clearance Decreased, Dehydration, Haematemesis, International Normalised Ratio Increased, Neutrophil Count Increased
on Sep 08, 2009 Male patient from FRANCE , 86 years of age, was treated with Ciflox (View Usage). After Ciflox was administered, patient had the following side effects: c-reactive protein increased, creatinine renal clearance decreased, dehydration, haematemesis, international normalised ratio increased, neutrophil count increased. Ciflox dosage: Total Daily Dose: 500 Mg Unit Dose: 500 Mg. During the same period patient was treated with PREVISCAN (Total Daily Dose: 15 Mg Unit Dose: 15 Mg) (View Previscan Review and Previscan Label ), SINEMET (Total Daily Dose: 100 Mg Unit Dose: 250 Mg) (View Sinemet Review and Sinemet Label ), SINEMET CR (Total Daily Dose: 100 Mg Unit Dose: 100 Mg) (View Sinemet Cr Review and Sinemet Cr Label ), IMOVANE (Total Daily Dose: 7.5 Mg Unit Dose: 7.5 Mg) (View Imovane Review and Imovane Label ), DILTIAZEM HCL (Total Daily Dose: 120 Mg Unit Dose: 60 Mg) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), NITROGLYCERIN (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Nitroglycerin Review and Nitroglycerin Label ), ZOCOR (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Zocor Review and Zocor Label ), FRACTAL (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Fractal Review and Fractal Label ). Patient was hospitalized.

6361165-8 | Erythema, Oral Disorder, Rash, Rash Pruritic, Toxic Skin Eruption
on Sep 08, 2009 Male patient from FRANCE , 71 years of age, was diagnosed with klebsiella infection and was treated with Ciflox (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, oral disorder, rash (What is rash?), rash pruritic, toxic skin eruption. Ciflox dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FURADANTIN (View Furadantin Review and Furadantin Label ), HEMIGOXINE (Total Daily Dose: 0.125 Mg Unit Dose: 0.125 Mg) (View Hemigoxine Review and Hemigoxine Label ), TEMERIT (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Temerit Review and Temerit Label ), BUMEX (Total Daily Dose: 1 Mg Unit Dose: 1 Mg) (View Bumex Review and Bumex Label ), COVERSYL (As Used: 10) (View Coversyl Review and Coversyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ).

6361162-2 | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Pulmonary Embolism
Patient was taking Ciflox (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, pulmonary embolism (What is pulmonary embolism?) on Sep 08, 2009 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with thrombosis and. Ciflox dosage: . During the same period patient was treated with HEPARINE SODIQUE PANPHARMA (View Heparine Sodique Panpharma Review and Heparine Sodique Panpharma Label ), CLAVENTIN (5 G/200 Mg (clavulanate Potassium, Ticarcillin Disodium)) (View Claventin Review and Claventin Label ), DEROXAT (View Deroxat Review and Deroxat Label ), SERESTA (View Seresta Review and Seresta Label ), HAVLANE (View Havlane Review and Havlane Label ), ORGARAN (View Orgaran Review and Orgaran Label ). Patient was hospitalized.